- Dr. Ramin M. Hakami, and three SSB Graduate Students, Have Research Article Published in Cell & Bioscienceby Megan Grant“Congratulations to three SSB graduate students in Dr. Hakami’s laboratory, Adeyemi Olanrewaju, Samson Omole, and Graham Matulis, for their important contributions to a main research article […]
- Andalibi and Alem receive funding for facility and building system upgrades support for Mason Biomedical Research Laboratoryby Megan GrantNov 15, 2021 by Elizabeth Grisham Ali Andalibi, Senior Associate Dean, College of Science, and Farhang Alem, Research Scientist, Center for Infectious Disease Research (formerly NCBID), Assistant Director of […]
- Hakami developing stable cell line for production of exosomes carrying EIAV GP90 glycoprotein for vaccine developmentby Megan Grant“Ramin Hakami, Associate Professor, School of Systems Biology, and researchers in his lab are purifying exosomes from the EIAV-gp90 cell line. They are doing so to demonstrate that exosomes have gp90 on the surface and […]
- Mason scientists explore herbal treatment for COVID-19by Megan Grant“Could an over-the-counter health “shot” help fight COVID-19? George Mason University researchers think it just might. Cell and Bioscience recently highlighted research led by Yuntao Wu and Ramin Hakami, […]
- Yuntao Wu and Ramin Hakami investigating COVID-19 therapiesby Megan GrantFor full article, click here
- Noble Life Sciences to Conduct Research on Mason SciTech Campus in Collaboration Agreement with National Center for Biodefense and Infectious Diseasesby Megan GrantFor full article, click here
- Innovation Pharmaceuticals and George Mason University Release Laboratory Testing Results Demonstrating Brilacidin’s COVID-19 Treatment Potentialby Megan GrantFor full article, click here
- The Telegraph (UK) highlights potential antibiotic from Komodo dragon bloodby Megan GrantMonique Van Hoek from the School of Systems Biology comments on the synthetic molecule created at Mason by combining two genes found in Komodo dragon blood. To Read […]
- Mason’s NCBID and University of Costa Rica Develop Equine Antibody-based Therapeutic to Neutralize Coronavirusby Megan GrantFor full article, click here
- Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Partner to Develop a Coronavirus (COVID-19) Vaccine using ChaESARTM Technologyby Megan GrantFor full article, click here
Center for Infectious Disease Research